Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy in pregnancy

T E Buekers1, T A Lallas

  • 1Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, USA.

Obstetrics and Gynecology Clinics of North America
|June 18, 1998
PubMed
Summary

Chemotherapy during pregnancy is not well-studied. While risks are higher in early pregnancy, later use may lead to premature birth and other complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polyarteritis nodosa of the vagina mimicking vaginal carcinoma.

Journal of lower genital tract disease·2015
Same author

A case of severe hidradenitis suppurativa contributing to a death and a review of the literature.

Journal of lower genital tract disease·2015
Same author

Asymptomatic lung carcinoma presenting with a large vulvar lesion.

Journal of lower genital tract disease·2006
Same author

Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.

Gynecologic oncology·2001
Same author

Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP).

Human mutation·2001
Same author

The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

Area of Science:

  • Obstetrics and Gynecology
  • Pediatric Oncology
  • Teratology

Background:

  • Limited data exists on chemotherapy's effects during pregnancy, primarily from case reports.
  • The National Cancer Institute registry has few documented cases of chemotherapy-exposed neonates.

Purpose of the Study:

  • To summarize the known effects of chemotherapy administration during pregnancy.
  • To highlight risks associated with different stages of fetal development.

Main Methods:

  • Literature review of existing case reports and small series.
  • Analysis of data from the National Cancer Institute's registry of neonates exposed to chemotherapy.

Main Results:

  • Chemotherapy during embryogenesis is linked to increased spontaneous abortions and major birth defects.
  • Chemotherapy in the second and third trimesters likely carries a background risk for fetal malformations.
  • Second and third-trimester chemotherapy may increase risks of premature birth, fetal growth restriction, myelosuppression, and stillbirths.

Conclusions:

  • Chemotherapy use in pregnancy requires careful consideration due to potential risks.
  • Timing of chemotherapy administration significantly influences fetal outcomes.
  • Further research is needed to fully understand and mitigate risks of prenatal chemotherapy exposure.

Related Experiment Videos